CLINICAL_TRIALS
trial_result
· 2017-11-30
Clinical Trial Update: Head to Head Study of Anti-VEGF Treatment. [Phase 4]
Summary
Phase 4 head-to-head trial of anti-VEGF treatment for age-related macular degeneration completed; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Age-related Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2017-11-30